BOLTON SECURITIES CORPORATION’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
BOLTON SECURITIES CORPORATION's NVO Position: Q2 2026 in Review
BOLTON SECURITIES CORPORATION reduced its Novo Nordisk (NVO) stake by 18% in Q2 2026, selling an estimated $109K and leaving 11,462 shares worth $549K. The position accounts for 0.02% of the portfolio, ranked #584.
BOLTON SECURITIES CORPORATION first reported a position in NVO in Q1 2025 and has held it in 4 quarters since. 1,362 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- BOLTON SECURITIES CORPORATION held 11,462 shares of Novo Nordisk worth $549K as of Q2 2026.
- BOLTON SECURITIES CORPORATION sold 2,547 Novo Nordisk shares in Q2 2026, an estimated $109K.
- Novo Nordisk made up 0.02% of BOLTON SECURITIES CORPORATION's portfolio in Q2 2026, its #584 holding.
- BOLTON SECURITIES CORPORATION first reported a position in Novo Nordisk in Q1 2025 and has held it in 4 quarters since.
- 1,362 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on BOLTON SECURITIES CORPORATION's 13F filing for Q2 2026.